The license will allow the company to perform all secondary packaging activities, including labeling, relabeling, cartooning, re-cartooning or adding additional information.
It is only awarded to companies who demonstrate that they meet legal requirements and Good Manufacturing Practices guidelines. Alongside the packaging green-light, DKSH was also awarded a license to manufacture preparations of dangerous drugs.
DKSH vice president of healthcare Richard Holloway voiced his delight with the licenses, which although not yet a government requirement, look set to become so.
“Secondary packaging is a critical step in the value chain which may affect the quality and integrity of pharmaceutical products,” he said in a statement.
“We are glad to have full capabilities and to have gained accreditation to perform this service well before it is required by the government body.”